The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription drug shortages that threaten the quality of patient care and increase hospital and health system costs. Responding to the agency’s request for comments as part of a September public meeting on the issue, AHA said Congress should strengthen drug shortage disclosure requirements for manufacturers; incentivize manufacturing contingency plans and/or redundancies; enhance production transparency requirements; enact shortage disclosure notification requirements for certain medical devices needed to administer drugs; assess drug shortages as a national security threat; and ask the Federal Trade Commission to consider the potential risk for shortages when it reviews drug company merger proposals. Among other actions, AHA recommended that FDA take additional steps to encourage manufacturers to produce drugs that are in shortage and prevent manufacturing shutdowns; establish a manufacturing quality rating system; disclose more information on the quality of outsourcing facilities that compound drugs in shortage; expand and improve its drug shortages list; and develop a list of critical drugs. 

Related News Articles

Headline
The Department of Health and Human Services as of July 1 has reduced by nearly 20% its backlog of Medicare appeals at the Administrative Law Judge level,…
Headline
Five hospital-led partnerships to improve community health will receive the AHA Dick Davidson NOVA Award Thursday at the AHA Leadership Summit in San Diego.
Headline
Atrium Health’s Carolinas Rehabilitation, Charlotte, N.C., will receive the 2019 AHA Quest for Quality Prize Thursday at the AHA Leadership Summit in San Diego.
Chairperson's File
Hospitals and health systems recognize that addressing social determinants of health is central to driving value and advancing overall well-being.
Headline
The Aspen Institute recently chose AHA Senior Vice President and Chief Medical Officer Jay Bhatt, D.O., to participate in its Health Innovators Fellowship.
Headline
The House Ways and Means Committee today launched a health task force to better address the needs of residents in rural and underserved communities.